Novel Insights into NOD-like Receptors in Renal Diseases

Overview

Journal Acta Pharmacol Sin

Specialty Pharmacology

Date 2022 Apr 2

PMID 35365780

Authors

Juan Jin

Tao-Jie Zhou

Gui-Ling Ren

Liang Cai

Xiao-Ming Meng

Affiliations

Soon will be listed here.

Abstract

Nucleotide-binding oligomerization domain-like receptors (NLRs), including NLRAs, NLRBs (also known as NAIPs), NLRCs, and NLRPs, are a major subfamily of pattern recognition receptors (PRRs). Owing to a recent surge in research, NLRs have gained considerable attention due to their involvement in mediating the innate immune response and perpetuating inflammatory pathways, which is a central phenomenon in the pathogenesis of multiple diseases, including renal diseases. NLRs are expressed in different renal tissues during pathological conditions, which suggest that these receptors play roles in acute kidney injury, obstructive nephropathy, diabetic nephropathy, IgA nephropathy, lupus nephritis, crystal nephropathy, uric acid nephropathy, and renal cell carcinoma, among others. This review summarises recent progress on the functions of NLRs and their mechanisms in the pathophysiological processes of different types of renal diseases to help us better understand the role of NLRs in the kidney and provide a theoretical basis for NLR-targeted therapy for renal diseases.

Citing Articles

Second Generation I-Body AD-214 Attenuates Unilateral Ureteral Obstruction (UUO)-Induced Kidney Fibrosis Through Inhibiting Leukocyte Infiltration and Macrophage Migration.

Cao Q, Foley M, Gill A, Chou A, Chen X, Pollock C Int J Mol Sci. 2024; 25(23).

PMID: 39684834 PMC: 11641963. DOI: 10.3390/ijms252313127.

Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis.

Li X, Shan Q, Wu X, Miao H, Zhao Y Cell Mol Life Sci. 2024; 81(1):480.

PMID: 39636415 PMC: 11621299. DOI: 10.1007/s00018-024-05532-5.

MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway.

Li J, Zhang J, Zhao X, Tian L Sci Rep. 2024; 14(1):20251.

PMID: 39215017 PMC: 11364842. DOI: 10.1038/s41598-024-67324-y.

Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications.

Ahmmed R, Hossen M, Ajadee A, Mahmud S, Ali M, Mollah M Sci Rep. 2024; 14(1):19133.

PMID: 39160196 PMC: 11333728. DOI: 10.1038/s41598-024-69302-w.

Mesoporous zinc-polyphenol nanozyme for attenuating renal ischemia-reperfusion injury.

Li Z, Qin J, Feng Y, Ding C, Guo Y, Zhao Z Nanomedicine (Lond). 2024; 19(24):2011-2026.

PMID: 39115910 PMC: 11485710. DOI: 10.1080/17435889.2024.2382667.

References

Leemans J, Kors L, Anders H, Florquin S . Pattern recognition receptors and the inflammasome in kidney disease. Nat Rev Nephrol. 2014; 10(7):398-414. DOI: 10.1038/nrneph.2014.91. View

Khare S, Dorfleutner A, Bryan N, Yun C, Radian A, de Almeida L . An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity. 2012; 36(3):464-76. PMC: 3315380. DOI: 10.1016/j.immuni.2012.02.001. View

Anders H, Schaefer L . Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol. 2014; 25(7):1387-400. PMC: 4073442. DOI: 10.1681/ASN.2014010117. View

Lamkanfi M, Dixit V . Mechanisms and functions of inflammasomes. Cell. 2014; 157(5):1013-22. DOI: 10.1016/j.cell.2014.04.007. View

Komada T, Muruve D . The role of inflammasomes in kidney disease. Nat Rev Nephrol. 2019; 15(8):501-520. DOI: 10.1038/s41581-019-0158-z. View

Anders H, Muruve D . The inflammasomes in kidney disease. J Am Soc Nephrol. 2011; 22(6):1007-18. DOI: 10.1681/ASN.2010080798. View

Schroder K, Tschopp J . The inflammasomes. Cell. 2010; 140(6):821-32. DOI: 10.1016/j.cell.2010.01.040. View

Ting J, Lovering R, Alnemri E, Bertin J, Boss J, Davis B . The NLR gene family: a standard nomenclature. Immunity. 2008; 28(3):285-7. PMC: 2630772. DOI: 10.1016/j.immuni.2008.02.005. View

Meunier E, Broz P . Evolutionary Convergence and Divergence in NLR Function and Structure. Trends Immunol. 2017; 38(10):744-757. DOI: 10.1016/j.it.2017.04.005. View

10.

Keestra-Gounder A, Tsolis R . NOD1 and NOD2: Beyond Peptidoglycan Sensing. Trends Immunol. 2017; 38(10):758-767. PMC: 5624830. DOI: 10.1016/j.it.2017.07.004. View

11.

Lupfer C, Kanneganti T . Unsolved Mysteries in NLR Biology. Front Immunol. 2013; 4:285. PMC: 3775000. DOI: 10.3389/fimmu.2013.00285. View

12.

Shigeoka A, Kambo A, Mathison J, King A, Hall W, da Silva Correia J . Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol. 2010; 184(5):2297-304. PMC: 3020136. DOI: 10.4049/jimmunol.0903065. View

13.

Girardin S, Boneca I, Viala J, Chamaillard M, Labigne A, Thomas G . Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003; 278(11):8869-72. DOI: 10.1074/jbc.C200651200. View

14.

Girardin S, Boneca I, Carneiro L, Antignac A, Jehanno M, Viala J . Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science. 2003; 300(5625):1584-7. DOI: 10.1126/science.1084677. View

15.

Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L . An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003; 4(7):702-7. DOI: 10.1038/ni945. View

16.

Travassos L, Carneiro L, Ramjeet M, Hussey S, Kim Y, Magalhaes J . Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2009; 11(1):55-62. DOI: 10.1038/ni.1823. View

17.

Askari N, Correa R, Zhai D, Reed J . Expression, purification, and characterization of recombinant NOD1 (NLRC1): A NLR family member. J Biotechnol. 2011; 157(1):75-81. PMC: 3249515. DOI: 10.1016/j.jbiotec.2011.10.007. View

18.

Inohara , Chamaillard , McDonald C, Nunez G . NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem. 2005; 74:355-83. DOI: 10.1146/annurev.biochem.74.082803.133347. View

19.

Kang J, Kim S, Cho H, Lee S . DAMPs activating innate immune responses in sepsis. Ageing Res Rev. 2015; 24(Pt A):54-65. DOI: 10.1016/j.arr.2015.03.003. View

20.

Wiersinga W, Leopold S, Cranendonk D, van der Poll T . Host innate immune responses to sepsis. Virulence. 2013; 5(1):36-44. PMC: 3916381. DOI: 10.4161/viru.25436. View